Study type: In vivo/preclinical · Status: Citation identity verified
A small erythropoietin derived non-hematopoietic peptide reduces cardiac inflammation, attenuates age associated declines in heart function and prolongs healthspan.
Frontiers in cardiovascular medicine · 2022
Study scale: Not reported in the declared source.
Citation only: Open source record
Product or molecular entity relationships
- ARA-290: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.
No public summary
No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.
Limitations and uncertainty
Not reported in the declared source.
Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.